Vaccines for the 21st Century

Kathleen R. Stratton, Jane S. Durch, and Robert S. Lawrence, Editors, Committee to Study Priorities for Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine

• 1 Front Matter; 2 Executive Summary; 3 Introduction; 4 Progress in Vaccine Development; 5 Considerations of Candidate Vaccines; 6 Overview of Analytic Approach and Results; 7 Review of the Analytical Model; 8 Ethical Considerations and Caveats; 9 Observations; 10 References; 11 Appendix 1: Borrelia burgdorferi; 12 Appendix 2: Chlamydia; 13 Appendix 3: Coccidioides Immitis; 14 Appendix 4: Cytomegalovirus; 15 Appendix 5: Enterotoxigenic E. coli; 16 Appendix 6: Epstein-Barr Virus; 17 Appendix 7: Helicobacter pylori; 18 Appendix 8: Hepatitis C; 19 Appendix 9: Herpes Simplex Virus; 20 Appendix 10: Histoplasma capsulatum; 21 Appendix 11: Human Paillomavirus; 22 Appendix 12: Influenza A and B; 23 Appendix 13: Insulin-Dependent Diabetes Mellitus; 24 Appendix 14: Melanoma; 25 Appendix 15: Multiple Sclerosis; 26 Appendix 16: Mycobacterium tuberculosis; 27 Appendix 17: Neisseria gonnorrhea; 28 Appendix 18: Neisseria meningitidis; 29 Appendix 19: Parainfluenza Virus; 30 Appendix 20: Respiratory Syncytial Virus; 31 Appendix 21: Rheumatoid Arthritis; 32 Appendix 22: Rotavirus; 33 Appendix 23: Shigella; 34 Appendix 24: Streptococcus, Group A; 35 Appendix 25: Streptococcus, Group B; 36 Appendix 26: Streptococcus pneumoniae; 37 Appendix 27: Information on accessing Electronic Spreadsheets; 38 Appendix 28: Summary of Workshops; 39 Appendix 29: Questions Posed to Outside Experts and List of Responders; 40 Index